Abstract
Epstein-Barr virus (EBV), one of the eight known human herpesviruses, generally infects subclinically. However, in certain circumstances, EBV causes overt diseases such as infectious mononucleosis (IM), usually a selflimiting disorder, by its primary infection. Additionally, it associates the development of various human malignancies including EBV genome-positive Burkitts lymphoma (BL) and undifferentiated nasopharyngeal carcinoma (NPC). More recently, EBV infection has been thought to be etiologically linked to the occurrence of lymphoproliferative disease (LPD) in immunologically compromised individuals either with hereditary or secondary condition, and the other lifethreatening diseases such as hemophagocytic lymphohistiocytosis (HLH) and chronic active EBV infection (CAEBV). This review mainly introduces, focuses and discusses on the recent advances of EBV infection regarding its pathogenetic mechanism(s), diagnosis and treatment.
Keywords: Epstein-Barr virus, herpesviruses, human diseases
Current Pediatric Reviews
Title: Epstein-Barr Virus Infection and its Pathogenetic Roles for Human Diseases
Volume: 5 Issue: 4
Author(s): Motohiko Okano
Affiliation:
Keywords: Epstein-Barr virus, herpesviruses, human diseases
Abstract: Epstein-Barr virus (EBV), one of the eight known human herpesviruses, generally infects subclinically. However, in certain circumstances, EBV causes overt diseases such as infectious mononucleosis (IM), usually a selflimiting disorder, by its primary infection. Additionally, it associates the development of various human malignancies including EBV genome-positive Burkitts lymphoma (BL) and undifferentiated nasopharyngeal carcinoma (NPC). More recently, EBV infection has been thought to be etiologically linked to the occurrence of lymphoproliferative disease (LPD) in immunologically compromised individuals either with hereditary or secondary condition, and the other lifethreatening diseases such as hemophagocytic lymphohistiocytosis (HLH) and chronic active EBV infection (CAEBV). This review mainly introduces, focuses and discusses on the recent advances of EBV infection regarding its pathogenetic mechanism(s), diagnosis and treatment.
Export Options
About this article
Cite this article as:
Okano Motohiko, Epstein-Barr Virus Infection and its Pathogenetic Roles for Human Diseases, Current Pediatric Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339609791317324
DOI https://dx.doi.org/10.2174/157339609791317324 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells
Clinical Cancer Drugs Phytochemistry and Pharmacognosy of Naturally Occurring Prenyloxyanthraquinones
Current Drug Targets Discovery and Development of Natural Products and their Derivatives as Photosensitizers for Photodynamic Therapy
Current Medicinal Chemistry The Clinical and Immunological Features of Patients with Primary Antibody Deficiencies
Endocrine, Metabolic & Immune Disorders - Drug Targets The Immunomodulatory Potential of Selected Bioactive Plant-Based Compounds in Breast Cancer: A Review
Anti-Cancer Agents in Medicinal Chemistry Current Status and Perspectives in Ceramide-Targeting Molecular Medicine
Current Pharmaceutical Design The Multifaceted Activities of Mammalian Defensins
Current Pharmaceutical Design Characterization of an mDock5-Specific Antibody and Tissue-Specific Expression and Subcellular Localization of mDock5
Protein & Peptide Letters Natural Product-Derived Small Molecule Activators of Hypoxia-Inducible Factor-1 (HIF-1)
Current Pharmaceutical Design Therapeutic Proteins in Tumors and Targeted Therapeutic Agents for Cancer Patients
Protein & Peptide Letters NBS1 Heterozygosity and Cancer Risk
Current Genomics Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Noscapine-loaded PLA Nanoparticles: Systematic Study of Effect of Formulation and Process Variables on Particle Size, Drug Loading and Entrapment Efficiency
Pharmaceutical Nanotechnology Protein Engineering: A New Frontier for Biological Therapeutics
Current Drug Metabolism Toward a Discipline of Pharmacoepigenomics
Current Pharmacogenomics Molecular Basis of Cardioprotection by Erythropoietin
Current Molecular Pharmacology The Role of Diffusion-weighted Imaging in Patients with Gastric Wall Thickening
Current Medical Imaging Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a Patient with Hodgkin's Lymphoma History from North of Iran
Infectious Disorders - Drug Targets Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants
Anti-Cancer Agents in Medicinal Chemistry Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy
Clinical Cancer Drugs